HIV/AIDS Topics IAS 2013: PrEP Shown Effective for Injection Drug Users [VIDEO]
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 16 July 2013 00:00
- Written by Gregory Fowler
Researchers at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur provided further details from the Bangkok Tenofovir Study, which showed that tenofovir pre-exposure prophylaxis, or PrEP, reduced the risk of HIV infection among people who inject drugs.
IAS 2013: Early Testing and Treatment Linked to Lower Sexual Risk in Thai Study [VIDEO]
- Details
- Category: HIV Prevention
- Published on Monday, 08 July 2013 00:00
- Written by Gregory Fowler
Gay men who started antiretroviral treatment during acute HIV infection achieved good viral load suppression in both blood and semen, and also reported reduced sexual risk behavior, researchers reported at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur.
Coverage of the 2013 International AIDS Society Conference
- Details
- Category: HIV Treatment
- Published on Saturday, 06 July 2013 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), June 30-July 3, in Kuala Lumpur, Malaysia.
Conference highlights include antiretroviral therapy strategies, treatment access, investigational agents for HIV and hepatitis C, management of HIV-related complications, biomedical HIV prevention, and HIV cure research.
HIVandHepatitis.com IAS 2013 conference section
7/6/13
IAS 2013: No Increase in Risk Behavior among People Taking ART, Meta-Analysis Shows
- Details
- Category: HIV Prevention
- Published on Sunday, 07 July 2013 00:00
- Written by Roger Pebody
One of the anxieties in relation to treatment as prevention is that it may discourage people with HIV from using condoms and other prevention methods. However, a meta-analysis has found no increase in risk-taking among people taking antiretroviral treatment, researchers reported at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur last week.
IAS 2013: iPrEx Participants Interested in Continuing HIV Pre-exposure Prophylaxis [VIDEO]
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Wednesday, 03 July 2013 00:00
- Written by Gregory Fowler
A majority of participants in an extension of the iPrEx pre-exposure prophylaxis (PrEP) trial said they would like ongoing open-label access to Truvada for HIV prevention, researchers reported at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur.
Web Design and Development by